Literature DB >> 973996

Measurement of theophylline in plasma by high performance liquid chromatography.

J G Kelly, W J Leahey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 973996      PMCID： PMC1428932          DOI： 10.1111/j.1365-2125.1976.tb00657.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Study of theophylline plasma levels after oral administration of new theophylline compounds.

Authors:  M TURNER-WARWICK
Journal:  Br Med J       Date:  1957-07-13

2.  An ultraviolet spectrophotometric method for the determination of theophylline and theobromine in blood and tissues.

Authors:  J A SCHACK; S H WAXLER
Journal:  J Pharmacol Exp Ther       Date:  1949-11       Impact factor: 4.030

3.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

4.  Specific gas chromatographic determination of xanthines and barbiturates by flash-heater N-butylation.

Authors:  M Kowblansky; B M Scheinthal; G D Cravello; L Chafetz
Journal:  J Chromatogr       Date:  1973-02-28

5.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875
  5 in total
  8 in total

1.  Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease.

Authors:  D R Taylor; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

2.  Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.

Authors:  D R Taylor; D Duffin; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

3.  Investigation of diurnal changes in the disposition of theophylline.

Authors:  D R Taylor; D Duffin; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

4.  Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.

Authors:  D R Taylor; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

5.  Pharmacokinetics of a microcrystalline theophylline preparation in patients with chronic obstructive airways disease.

Authors:  R K Elwood; J G Kelly; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

6.  Plasma theophylline concentrations following the oral administration of microcrystalline theophylline and a new sustained-release theophylline preparation to normal subjects.

Authors:  C J Russell; R K Elwood; C Kinney; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

7.  Prediction of optimum oral theophylline dose in patients with obstructive airways disease.

Authors:  D R Taylor; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

8.  Patient compliance with oral theophylline therapy.

Authors:  D R Taylor; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.